Possible link between steatotic liver diseases, severe COVID‑19 and cognitive impairment in post‑COVID‑19 syndrome, 2025, Reuken et al

Discussion in 'Long Covid research' started by forestglip, Apr 10, 2025.

  1. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    2,065
    Possible link between steatotic liver diseases, severe COVID‑19 and cognitive impairment in post‑COVID‑19 syndrome

    Philipp A. Reuken, Freya Wagner, Kathrin Finke, Christina Lemhöfer, Christian Puta, Sven Stengel, André Scherag, Jan‑Christoph Lewejohann, Andreas Stallmach, Stefanie Quickert

    [Line breaks added]


    Purpose
    Steatotic liver diseases (SLD) have become more prevalent over the last decade and are associated not only with cardiometabolic diseases but also with psychological symptoms (depression, fatigue). These symptoms are also common in post-COVID syndrome (PCS). Therefore, the aim of the study was to analyze the burden of SLD in PCS patients.

    Methods
    We systematically screened all PCS patients from our post-COVID outpatient clinic using transient elastography, structured questionnaires for neurocognitive evaluation and blood sample analysis. Controls without PCS and without known liver diseases were also recruited and assessed with the same approach.

    Results
    560 PCS patients and 103 healthy controls were included. The overall prevalence of SLD was high in both cohorts (57 vs. 53%).

    PCS patients with SLD were more frequently male (41 vs. 24%), older (52 vs. 44 years) and had more cardio-metabolic diseases (87.0 vs. 46.4%).

    Cognitive impairment was more related to SLD in PCS patients than in the no-SLD group (OR: 1.68, CI: 1.14–2.46, p = 0.008). The presence of SLD was related to severe COVID-19 with hospitalization (OR: 2.91, CI: 1.85–4.56, p < 0.001).

    Within 1 year of the follow-up, 152 of 289 patients described a resolution in PCS irrespective of the presence or absence of SLD (log-rank p = 0.96).

    Conclusions
    SLD is associated with severe COVID-19 and cognitive dysfunction in PCS. Longitudinal studies are needed to assess the role of hepatic steatosis, development of post-acute infection regulation (e.g., SARS-CoV-2) and to differentiate between SLD-associated symptoms and PCS.

    Link | PDF (Infection) [Open Access]
     
    Turtle, Utsikt and Sean like this.
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,659
    Location:
    Aotearoa New Zealand
    Doesn't look particularly informative.

     
    Dolphin, Trish, Eleanor and 2 others like this.

Share This Page